ART makes move to commercialize breast imaging device in Canada

ART Advanced Research Technologies Inc. last week announced that it has filed a Medical Device License Application with Health Canada to begin the commercialization of its SoftScan breast imaging device.

ART is seeking regulatory approval of SoftScan as an adjunct to x-ray mammography.  It uses a non-invasive and pain-free approach based on time-domain optical imaging technology which will enable the characterization of breast tumors by clinicians as benign or malignant, without exposing the patients to potentially harmful radiation, the company said.

Trimed Popup
Trimed Popup